Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity (Unaudited)

v3.23.1
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained earnings
Accumulated other comprehensive income
Beginning Balance at Dec. 31, 2021 $ 370,227 $ 23 $ 299,463 $ 69,272 $ 1,469
Beginning Balance, shares at Dec. 31, 2021   22,731,586      
Stock-based compensation 2,665   2,665    
Employee stock purchases 915   915    
Employee stock purchases, shares   30,558      
Vesting of restricted stock units (958)   (958)    
Vesting of restricted stock units, shares   73,495      
Shares withheld related to net restricted stock settlement (94)   (94)    
Shares withheld related to net restricted stock settlement, shares   (2,666)      
Stock options exercised 29   29    
Stock options exercised, shares   3,499      
Net loss (14,214)     (14,214)  
Other comprehensive income (loss) (285)       (285)
Ending Balance at Mar. 31, 2022 358,285 $ 23 302,020 55,058 1,184
Ending Balance, shares at Mar. 31, 2022   22,836,472      
Beginning Balance at Dec. 31, 2022 297,406 $ 23 312,126 (14,500) (243)
Beginning Balance, shares at Dec. 31, 2022   22,941,643      
Stock-based compensation 3,442   3,442    
Employee stock purchases 630   630    
Employee stock purchases, shares   47,676      
Vesting of restricted stock units (454)   (454)    
Vesting of restricted stock units, shares   77,530      
Shares withheld related to net restricted stock settlement (1)   (1)    
Shares withheld related to net restricted stock settlement, shares   (495)      
Stock options exercised $ 384   384    
Stock options exercised, shares 54,432 54,432      
Net loss $ (20,349)     (20,349)  
Other comprehensive income (loss) 239       239
Ending Balance at Mar. 31, 2023 $ 281,297 $ 23 $ 316,127 $ (34,849) $ (4)
Ending Balance, shares at Mar. 31, 2023   23,120,786